Send the following on WhatsApp
Continue to ChatTocilizumab, neumonía grave por COVID-19 y H12O https://cendoc.h12o.es/blog/2020/07/20/tocilizumab-neumonia-grave-por-covid-19-y-h12o/
Tocilizumab, neumonía grave por COVID-19 y H12O https://cendoc.h12o.es/blog/2020/07/20/tocilizumab-neumonia-grave-por-covid-19-y-h12o/